| 检索策略 |
|---|
| #1 “Rectal Neoplasms”[Mesh] |
| #2 ((((((((Neoplasm, Rectal[Title/Abstract]) OR (Rectum Neoplasms[Title/Abstract])) OR (Neoplasm, Rectum[Title/Abstract])) OR (Rectum Neoplasm[Title/Abstract])) OR (Rectal Tumors[Title/Abstract])) OR (Neoplasms, Rectal[Title/Abstract])) OR (Rectum Cancers[Title/Abstract])) OR (Rectal Cancers[Title/Abstract])) OR (Cancer, Rectum[Title/Abstract])) |
| #3 (#1 OR #2) |
| #4 "Neoadjuvant Therapy"[Mesh] |
| #5 ((((((Neoadjuvant Treatment[Title/Abstract]) OR (Neoadjuvant Radiotherapy[Title/Abstract])) OR (Neoadjuvant Chemotherapy[Title/Abstract])) OR (Neoadjuvant Chemoradiation[Title/Abstract])) OR (Induction chemotherapy[Title/Abstract])) OR (Consolidation chemotherapy[Title/Abstract])) OR (Perioperative chemotherapy[Title/Abstract]) |
| #6 (#4 OR #5) |
| #7 "Radiotherapy"[Mesh] |
| #8 ((((((Radiation Therapy[Title/Abstract]) OR (Radiation Treatment[Title/Abstract])) OR (Targeted Radiotherapy[Title/Abstract])) OR (Targeted Radiation Therapy[Title/Abstract])) OR (standard chemoradiotherapy[Title/Abstract])) OR (chemoradiotherapy[Title/Abstract])) OR (Neoadjuvant Chemoradiation[Title/Abstract]) |
| #9 (#7 OR #8) |
| #10(((randomized controlled trial[Publication Type]) OR (randomized[Title/Abstract])) OR (cohort study[Title/Abstract])) OR (retrospective cohort study[Title/Abstract]) |
| #11 (#3 AND #6 AND #9 AND #10) |
Fig 4 Odds ratio (OR) and 95%CI of all regimens from network Meta-analysis for six indicators 注(note):中间深色板块将联赛表分为上下两部分,OR(odds ratio) 值代表列与行两方案的比值比[different interventions in the middle blocle divded the graph into upper and lower triangle;the OR (odds ratio) value represents the odds ratio of the two prototocols in the column and row];95%CI 不包括1.00代表两方案有显著性差异,用灰色方块表示,且加粗标有星号(95%CI excluding 1.00 means there is a significant difference between the two protocols and is represented by a gray square with a bold asterisk)。